NILOTINIB

NILOTINIB was reported 29571 times

NILOTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYTOGENETIC ANALYSIS ABNORMAL 498 0.4752
1 CHRONIC MYELOID LEUKAEMIA RECURRENT 194 0.3547
2 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 130 0.2915
3 PHILADELPHIA CHROMOSOME POSITIVE 186 0.2544
4 SPLENITIS 32 0.2286
5 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 256 0.2075
6 POLYMERASE CHAIN REACTION POSITIVE 71 0.2034
7 AMAUROSIS FUGAX 201 0.1866
8 CHRONIC MYELOID LEUKAEMIA 840 0.1818
9 PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA 17 0.1771
10 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 82 0.1643
11 PERIPHERAL ARTERY STENOSIS 77 0.1608
12 XANTHELASMA 16 0.1391
13 GENE MUTATION IDENTIFICATION TEST POSITIVE 53 0.1259
14 BLAST CELL CRISIS 37 0.1114
15 INTERMITTENT CLAUDICATION 167 0.1053
16 VERTEBRAL ARTERY STENOSIS 16 0.1032
17 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 413 0.1011
18 ARTERIAL INSUFFICIENCY 13 0.0703
19 VERTEBRAL ARTERY OCCLUSION 14 0.0619
20 CEREBRAL ARTERY STENOSIS 28 0.0574
21 CHROMOSOME ANALYSIS ABNORMAL 14 0.0551
22 ARTERIOSCLEROSIS 510 0.0541
23 CAROTID ARTERY STENOSIS 175 0.0501
24 PERIPHERAL ARTERY OCCLUSION 66 0.0469
25 BLOOD URIC ACID ABNORMAL 19 0.0466
26 SECOND PRIMARY MALIGNANCY 379 0.0455
27 VASCULAR STENOSIS 15 0.0436
28 PERIPHERAL VASCULAR DISORDER 222 0.0430
29 HEPATIC INFECTION 54 0.0423
30 ARTERIAL STENOSIS 37 0.0422
31 URINARY TRACT DISORDER 188 0.0417
32 BASOPHIL COUNT INCREASED 31 0.0409
33 CENTRAL NERVOUS SYSTEM LEUKAEMIA 16 0.0407
34 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 20 0.0398
35 CHLOROMA 16 0.0379
36 BLAST CELLS PRESENT 18 0.0374
37 LEUKAEMIA RECURRENT 63 0.0372
38 CAROTID ARTERIOSCLEROSIS 38 0.0368
39 EXPOSURE VIA FATHER 48 0.0368
40 ARTERIAL DISORDER 70 0.0366
41 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 23 0.0351
42 LIPASE INCREASED 262 0.0342
43 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 78 0.0302
44 GENE MUTATION 58 0.0293
45 CHIKUNGUNYA VIRUS INFECTION 16 0.0286
46 ARTERITIS 17 0.0269
47 ONCOLOGIC COMPLICATION 26 0.0269
48 FOOD INTERACTION 47 0.0266
49 HAEMORRHAGIC STROKE 208 0.0266
50 LEFT ATRIAL ENLARGEMENT 14 0.0260
51 REMISSION NOT ACHIEVED 16 0.0257
52 CONCOMITANT DISEASE PROGRESSION 49 0.0251
53 GASTROINTESTINAL STROMAL TUMOUR 66 0.0248
54 BLAST CELL COUNT INCREASED 26 0.0248
55 BLOOD BILIRUBIN UNCONJUGATED INCREASED 18 0.0248
56 FULL BLOOD COUNT INCREASED 29 0.0243
57 ACUTE LYMPHOCYTIC LEUKAEMIA 67 0.0236
58 CORONARY ARTERY STENOSIS 117 0.0232
59 DELIVERY 15 0.0228
60 PANCREATIC ENZYMES INCREASED 33 0.0225
61 CHYLOTHORAX 16 0.0222
62 GRANULOMA SKIN 18 0.0219
63 AMYLASE INCREASED 80 0.0217
64 SPLENOMEGALY 248 0.0211
65 RENAL ARTERY STENOSIS 29 0.0210
66 BLOOD LACTATE DEHYDROGENASE ABNORMAL 14 0.0206
67 LYMPHOCYTE COUNT ABNORMAL 23 0.0204
68 LEUKAEMIA 191 0.0202
69 ELECTROCARDIOGRAM QT PROLONGED 721 0.0200
70 GENERALISED OEDEMA 248 0.0200
71 DRUG RESISTANCE 514 0.0200
72 TEMPORAL ARTERITIS 18 0.0194
73 HYDROTHORAX 16 0.0193
74 CONCOMITANT DISEASE AGGRAVATED 118 0.0191
75 OCULAR DISCOMFORT 211 0.0188
76 BLOOD BILIRUBIN ABNORMAL 23 0.0180
77 PRODUCT BLISTER PACKAGING ISSUE 18 0.0173
78 THROMBOCYTOSIS 62 0.0169
79 ACQUIRED GENE MUTATION 22 0.0168
80 PERIPHERAL ISCHAEMIA 68 0.0166
81 MYOCARDIAL ISCHAEMIA 185 0.0162
82 NORMAL NEWBORN 88 0.0162
83 DYSLIPIDAEMIA 82 0.0161
84 LOSS OF THERAPEUTIC RESPONSE 51 0.0160
85 PRINZMETAL ANGINA 15 0.0151
86 CAROTID ARTERY OCCLUSION 54 0.0148
87 SKIN SENSITISATION 15 0.0145
88 PERIPHERAL ARTERY THROMBOSIS 20 0.0142
89 ARTERIAL OCCLUSIVE DISEASE 110 0.0140
90 HAEMATOTOXICITY 128 0.0135
91 STENOSIS 25 0.0133
92 CYTOGENETIC ABNORMALITY 15 0.0133
93 WHITE BLOOD CELL COUNT INCREASED 510 0.0133
94 BLOOD BILIRUBIN INCREASED 357 0.0132
95 PLATELET COUNT INCREASED 172 0.0132
96 VASCULAR CALCIFICATION 14 0.0131
97 HEAD DISCOMFORT 232 0.0131
98 CEREBRAL ARTERY OCCLUSION 14 0.0131
99 PLEURAL EFFUSION 792 0.0130
100 ACUTE CORONARY SYNDROME 107 0.0129
101 CYTOPENIA 158 0.0129
102 AORTIC ARTERIOSCLEROSIS 33 0.0128
103 WHITE BLOOD CELL DISORDER 34 0.0127
104 ANGINA PECTORIS 363 0.0127
105 CAROTID ARTERY DISEASE 16 0.0126
106 ANGINA UNSTABLE 81 0.0125
107 INFARCTION 84 0.0123
108 ESSENTIAL HYPERTENSION 22 0.0120
109 ASPARTATE AMINOTRANSFERASE ABNORMAL 18 0.0118
110 WHITE BLOOD CELL COUNT ABNORMAL 75 0.0117
111 VENOUS OCCLUSION 21 0.0115
112 GANGRENE 69 0.0114
113 ANGIOPATHY 63 0.0112
114 CORONARY ARTERY DISEASE 340 0.0112
115 LEFT VENTRICULAR HYPERTROPHY 47 0.0110
116 RED BLOOD CELL COUNT ABNORMAL 16 0.0109
117 PLATELET COUNT ABNORMAL 64 0.0106
118 MYELOFIBROSIS 32 0.0106
119 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 23 0.0105
120 INVESTIGATION ABNORMAL 15 0.0104
121 ARTERIAL THROMBOSIS 20 0.0103
122 ALTERED STATE OF CONSCIOUSNESS 220 0.0101
123 ACUTE MYOCARDIAL INFARCTION 296 0.0100
124 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 14 0.0099
125 DISCOURAGEMENT 23 0.0098
126 HAEMATEMESIS 244 0.0096
127 PERICARDIAL EFFUSION 222 0.0096
128 DENGUE FEVER 22 0.0096
129 LEUKOCYTOSIS 173 0.0096
130 HYPERCHOLESTEROLAEMIA 92 0.0095
131 BLOOD URIC ACID INCREASED 55 0.0095
132 ALANINE AMINOTRANSFERASE ABNORMAL 20 0.0095
133 SPLEEN DISORDER 16 0.0094
134 LIPIDS INCREASED 19 0.0094
135 BILIRUBIN CONJUGATED INCREASED 22 0.0094
136 CARDIOVASCULAR INSUFFICIENCY 15 0.0092
137 AORTIC STENOSIS 32 0.0092
138 PHOTOPHOBIA 172 0.0091
139 VERTIGO POSITIONAL 16 0.0091
140 HYPERBILIRUBINAEMIA 93 0.0090
141 ASCITES 263 0.0089
142 SUPRAVENTRICULAR EXTRASYSTOLES 30 0.0089
143 CEREBELLAR INFARCTION 15 0.0089
144 DIPLOPIA 230 0.0088
145 LAZINESS 15 0.0088
146 PLATELET DISORDER 22 0.0087
147 CYTOMEGALOVIRUS COLITIS 20 0.0087
148 ACUTE LEUKAEMIA 14 0.0087
149 PANCREATITIS 452 0.0085
150 VASCULAR OCCLUSION 18 0.0085
151 HAEMOGLOBIN ABNORMAL 54 0.0084
152 DRUG INTOLERANCE 809 0.0084
153 FEELING OF DESPAIR 39 0.0084
154 LYMPHOCYTE COUNT INCREASED 27 0.0083
155 GRAFT VERSUS HOST DISEASE IN SKIN 18 0.0082
156 BONE PAIN 477 0.0081
157 FACIAL PARALYSIS 67 0.0079
158 PRESYNCOPE 191 0.0078
159 ISCHAEMIC CARDIOMYOPATHY 24 0.0078
160 LACTOSE INTOLERANCE 20 0.0078
161 CORONARY ARTERY OCCLUSION 107 0.0078
162 PLATELET COUNT DECREASED 829 0.0078
163 PIGMENTATION DISORDER 48 0.0078
164 POOR PERIPHERAL CIRCULATION 33 0.0077
165 ELECTROCARDIOGRAM T WAVE INVERSION 17 0.0077
166 APLASIA 15 0.0077
167 HYPERLIPIDAEMIA 91 0.0076
168 BLINDNESS 309 0.0076
169 ARTERIOSCLEROSIS CORONARY ARTERY 50 0.0075
170 NECROSIS 42 0.0075
171 DIASTOLIC DYSFUNCTION 23 0.0074
172 SKIN TOXICITY 42 0.0074
173 HEPATOSPLENOMEGALY 19 0.0074
174 RECURRENT CANCER 30 0.0073
175 MITRAL VALVE INCOMPETENCE 83 0.0073
176 CARDIO-RESPIRATORY ARREST 306 0.0073
177 HYPERURICAEMIA 30 0.0073
178 BONE MARROW FAILURE 148 0.0073
179 BONE MARROW DISORDER 22 0.0073
180 MALIGNANT NEOPLASM PROGRESSION 740 0.0072
181 ISCHAEMIA 33 0.0072
182 MONOCYTE COUNT INCREASED 26 0.0072
183 DECREASED IMMUNE RESPONSIVENESS 70 0.0071
184 BLOOD PHOSPHORUS DECREASED 26 0.0071
185 PANCREATIC DISORDER 35 0.0071
186 GASTROINTESTINAL TOXICITY 34 0.0071
187 YELLOW SKIN 33 0.0070
188 ELECTROCARDIOGRAM ABNORMAL 55 0.0070
189 LEFT VENTRICULAR FAILURE 24 0.0070
190 BLOOD CREATININE ABNORMAL 24 0.0069
191 CEREBRAL INFARCTION 167 0.0068
192 RED CELL DISTRIBUTION WIDTH INCREASED 28 0.0067
193 HEPATOMEGALY 66 0.0067
194 HAEMATURIA 227 0.0066
195 DIABETIC FOOT 20 0.0065
196 RED BLOOD CELL COUNT INCREASED 18 0.0065
197 THERAPEUTIC RESPONSE DELAYED 18 0.0064
198 TRICUSPID VALVE INCOMPETENCE 51 0.0064
199 CEREBRAL ISCHAEMIA 33 0.0064
200 INJURY 449 0.0064
201 VIITH NERVE PARALYSIS 22 0.0064
202 SKIN PAPILLOMA 25 0.0062
203 PANCYTOPENIA 345 0.0062
204 CARDIAC TAMPONADE 29 0.0061
205 HEPATIC PAIN 26 0.0061
206 HAEMOGLOBIN DECREASED 623 0.0061
207 NEUTROPHIL COUNT ABNORMAL 17 0.0060
208 PULMONARY HYPERTENSION 123 0.0059
209 GASTRITIS 155 0.0059
210 RASH GENERALISED 152 0.0059
211 GRAFT VERSUS HOST DISEASE 42 0.0058
212 HEPATIC ENZYME ABNORMAL 29 0.0058
213 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 19 0.0057
214 THROMBOCYTOPENIA 640 0.0057
215 ORTHOPNOEA 18 0.0056
216 CARDIOMEGALY 69 0.0056
217 PRODUCT SUPPLY ISSUE 40 0.0056
218 AUTOIMMUNE THYROIDITIS 21 0.0055
219 LOW DENSITY LIPOPROTEIN INCREASED 43 0.0055
220 GAMMA-GLUTAMYLTRANSFERASE INCREASED 123 0.0055
221 FULL BLOOD COUNT ABNORMAL 58 0.0055
222 MULTIPLE-DRUG RESISTANCE 17 0.0055
223 SPINAL PAIN 64 0.0055
224 GLUCOSE TOLERANCE IMPAIRED 32 0.0054
225 PERIORBITAL OEDEMA 28 0.0054
226 HYPERGLYCAEMIA 196 0.0054
227 TINNITUS 247 0.0054
228 CEREBROVASCULAR DISORDER 16 0.0053
229 NEOPLASM RECURRENCE 18 0.0053
230 HEPATOTOXICITY 118 0.0053
231 HEMIPLEGIA 44 0.0053
232 BLOOD POTASSIUM ABNORMAL 14 0.0052
233 CONJUNCTIVAL HAEMORRHAGE 20 0.0052
234 MYOCARDIAL INFARCTION 900 0.0052
235 GOITRE 21 0.0051
236 THYROID NEOPLASM 14 0.0051
237 BLOOD LACTATE DEHYDROGENASE INCREASED 80 0.0050
238 BRAIN HERNIATION 15 0.0050
239 COMA 238 0.0050
240 CHRONIC GRAFT VERSUS HOST DISEASE 18 0.0050
241 ARTERIOSPASM CORONARY 20 0.0050
242 EATING DISORDER 105 0.0049
243 FULL BLOOD COUNT DECREASED 99 0.0049
244 MYALGIA 835 0.0049
245 ISCHAEMIC STROKE 87 0.0049
246 EXERCISE TOLERANCE DECREASED 28 0.0049
247 DEAFNESS NEUROSENSORY 16 0.0049
248 RED BLOOD CELL COUNT DECREASED 139 0.0049
249 EYE PAIN 273 0.0048
250 DIABETES MELLITUS 367 0.0048
251 ABORTION 14 0.0048
252 BLOOD CREATININE DECREASED 15 0.0048
253 POLYMYALGIA RHEUMATICA 15 0.0047
254 RENAL PAIN 50 0.0047
255 CARDIAC FAILURE CHRONIC 20 0.0047
256 NEUTROPHIL COUNT INCREASED 48 0.0047
257 ACUTE MYELOID LEUKAEMIA 73 0.0047
258 FLUID RETENTION 238 0.0047
259 IRON DEFICIENCY 21 0.0047
260 BENIGN PROSTATIC HYPERPLASIA 24 0.0046
261 TUMOUR MARKER INCREASED 22 0.0046
262 LUNG INFILTRATION 40 0.0045
263 PROCTALGIA 29 0.0045
264 BLOOD BLISTER 14 0.0045
265 OVERWEIGHT 24 0.0045
266 ORGAN FAILURE 18 0.0045
267 AORTIC VALVE INCOMPETENCE 19 0.0045
268 APPARENT DEATH 16 0.0044
269 PAPILLOEDEMA 20 0.0044
270 TRANSIENT ISCHAEMIC ATTACK 149 0.0044
271 CARDIOVASCULAR DISORDER 112 0.0044
272 APLASTIC ANAEMIA 23 0.0044
273 PLEURISY 26 0.0044
274 EPIGASTRIC DISCOMFORT 17 0.0043
275 PANCREATITIS ACUTE 97 0.0043
276 LIVER DISORDER 190 0.0043
277 JAUNDICE 115 0.0043
278 FACIAL PARESIS 15 0.0042
279 NEPHROTIC SYNDROME 29 0.0042
280 EOSINOPHIL COUNT INCREASED 35 0.0042
281 SKIN DISORDER 139 0.0042
282 HAEMOGLOBIN INCREASED 19 0.0042
283 HAEMATOCRIT DECREASED 82 0.0041
284 IRON DEFICIENCY ANAEMIA 38 0.0041
285 BLOOD CHOLESTEROL ABNORMAL 19 0.0041
286 ANAEMIA 783 0.0041
287 HYPERTRIGLYCERIDAEMIA 24 0.0041
288 SENSORY LOSS 33 0.0041
289 TRANSAMINASES INCREASED 90 0.0040
290 VENTRICULAR EXTRASYSTOLES 42 0.0040
291 LEFT VENTRICULAR DYSFUNCTION 27 0.0040
292 BLOOD DISORDER 32 0.0040
293 INTERVERTEBRAL DISC DISORDER 17 0.0040
294 HYPOTHYROIDISM 127 0.0040
295 BLOOD CHOLESTEROL INCREASED 185 0.0040
296 THERAPY NON-RESPONDER 178 0.0040
297 PULMONARY OEDEMA 177 0.0039
298 THERAPEUTIC RESPONSE DECREASED 239 0.0039
299 CARDIAC MURMUR 34 0.0039
300 ABDOMINAL PAIN UPPER 804 0.0039
301 CEREBROVASCULAR ACCIDENT 656 0.0039
302 MYELODYSPLASTIC SYNDROME 56 0.0039
303 TACHYCARDIA 342 0.0038
304 DEAFNESS 100 0.0038
305 PROSTATOMEGALY 15 0.0038
306 RASH 1662 0.0038
307 HYPOACUSIS 164 0.0038
308 SYNCOPE 380 0.0038
309 BLOOD CREATINE PHOSPHOKINASE INCREASED 109 0.0038
310 WHITE BLOOD CELL COUNT DECREASED 409 0.0038
311 DEATH 3234 0.0038
312 INTRACRANIAL ANEURYSM 15 0.0037
313 OEDEMA 202 0.0037
314 CARDIAC FAILURE 298 0.0037
315 BLOOD IRON DECREASED 44 0.0037
316 ATRIAL FIBRILLATION 361 0.0037
317 BUNDLE BRANCH BLOCK RIGHT 17 0.0037
318 PARALYSIS 53 0.0037
319 ALANINE AMINOTRANSFERASE INCREASED 226 0.0037
320 VARICOSE VEIN 19 0.0037
321 ARRHYTHMIA 174 0.0037
322 GASTRIC INFECTION 14 0.0037
323 CHOLELITHIASIS 120 0.0037
324 TUMOUR LYSIS SYNDROME 32 0.0036
325 EMOTIONAL DISTRESS 439 0.0036
326 NEOPLASM MALIGNANT 242 0.0036
327 ABDOMINAL PAIN 826 0.0035
328 PNEUMONIA FUNGAL 14 0.0035
329 CHEST PAIN 654 0.0035
330 BLOOD TRIGLYCERIDES INCREASED 62 0.0035
331 ACUTE GRAFT VERSUS HOST DISEASE 16 0.0035
332 HAEMORRHOIDS 68 0.0035
333 CARDIOTOXICITY 31 0.0035
334 BLOOD UREA INCREASED 58 0.0035
335 THERAPY CHANGE 34 0.0035
336 DEAFNESS UNILATERAL 19 0.0034
337 EAR PAIN 67 0.0034
338 ASPHYXIA 28 0.0034
339 BLOOD COUNT ABNORMAL 52 0.0034
340 NEOPLASM PROGRESSION 119 0.0034
341 ATELECTASIS 33 0.0034
342 HEPATIC FUNCTION ABNORMAL 127 0.0034
343 PERICARDITIS 57 0.0034
344 RHINITIS ALLERGIC 15 0.0034
345 HEMIPARESIS 57 0.0034
346 DERMATITIS ALLERGIC 42 0.0033
347 FOLLICULITIS 35 0.0033
348 SKIN LESION 91 0.0033
349 MUSCULOSKELETAL PAIN 173 0.0033
350 BLOOD ALKALINE PHOSPHATASE INCREASED 82 0.0033
351 LIVER FUNCTION TEST ABNORMAL 96 0.0033
352 FEBRILE BONE MARROW APLASIA 14 0.0033
353 PYREXIA 1135 0.0033
354 FACE OEDEMA 55 0.0033
355 INTERVERTEBRAL DISC PROTRUSION 71 0.0032
356 HYPOKINESIA 47 0.0032
357 MUSCULOSKELETAL CHEST PAIN 50 0.0032
358 HYPERCHLORHYDRIA 19 0.0032
359 ASPARTATE AMINOTRANSFERASE INCREASED 171 0.0032
360 MOVEMENT DISORDER 103 0.0032
361 NO THERAPEUTIC RESPONSE 39 0.0032
362 VEIN DISORDER 16 0.0032
363 SEPSIS 356 0.0032
364 ONYCHOMYCOSIS 14 0.0032
365 PRURITUS GENERALISED 69 0.0032
366 DYSPEPSIA 313 0.0032
367 CARDIOMYOPATHY 47 0.0032
368 THYROID DISORDER 49 0.0032
369 TROPONIN INCREASED 24 0.0032
370 GINGIVAL BLEEDING 43 0.0031
371 DECREASED APPETITE 731 0.0031
372 MOUTH HAEMORRHAGE 23 0.0031
373 ATRIAL FLUTTER 25 0.0031
374 HEPATIC STEATOSIS 58 0.0031
375 ULCER 49 0.0031
376 CARDIAC DISORDER 288 0.0031
377 PETECHIAE 32 0.0031
378 ALOPECIA 602 0.0031
379 DISEASE COMPLICATION 14 0.0031
380 PALLOR 83 0.0030
381 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 549 0.0030
382 DYSGRAPHIA 20 0.0030
383 PRODUCT AVAILABILITY ISSUE 69 0.0030
384 CHILLS 355 0.0030
385 FURUNCLE 24 0.0030
386 LUNG INFECTION 47 0.0030
387 EYE HAEMORRHAGE 40 0.0030
388 PAIN IN EXTREMITY 880 0.0030
389 ANAL FISSURE 16 0.0030
390 TOOTHACHE 54 0.0030
391 DUODENAL ULCER 21 0.0030
392 STENT PLACEMENT 24 0.0030
393 PRURITUS 1141 0.0030
394 PULMONARY CONGESTION 39 0.0030
395 SKIN ATROPHY 17 0.0030
396 NIGHT SWEATS 95 0.0029
397 CHOLECYSTITIS 35 0.0029
398 SUDDEN DEATH 31 0.0029
399 HYPERKERATOSIS 16 0.0029
400 GOUT 52 0.0029
401 APHASIA 87 0.0029
402 RASH PRURITIC 156 0.0029
403 HEPATITIS 73 0.0029
404 RHINITIS 23 0.0028
405 TYPE 2 DIABETES MELLITUS 96 0.0028
406 ASTHENIA 1071 0.0028
407 GASTRIC ULCER 54 0.0028
408 PAPULE 20 0.0028
409 HYPERTENSION 600 0.0028
410 EJECTION FRACTION DECREASED 44 0.0028
411 PULMONARY ARTERIAL HYPERTENSION 41 0.0028
412 PULMONARY TOXICITY 20 0.0028
413 SCIATICA 45 0.0028
414 DIVERTICULUM 20 0.0028
415 MUSCLE SPASMS 515 0.0028
416 DERMATITIS ACNEIFORM 17 0.0028
417 DYSPNOEA EXERTIONAL 105 0.0028
418 MYOSITIS 25 0.0028
419 TREATMENT FAILURE 230 0.0028
420 FLANK PAIN 26 0.0028
421 BLINDNESS UNILATERAL 39 0.0028
422 BLOOD CREATININE INCREASED 180 0.0028
423 FATIGUE 2140 0.0027
424 GENERAL PHYSICAL HEALTH DETERIORATION 317 0.0027
425 PHOTOSENSITIVITY REACTION 45 0.0027
426 EXTRASYSTOLES 19 0.0027
427 DEMENTIA 76 0.0027
428 HAEMOLYSIS 21 0.0027
429 LEUKOPENIA 136 0.0027
430 ATRIOVENTRICULAR BLOCK 21 0.0027
431 COUGH 758 0.0027
432 HEPATIC ENZYME INCREASED 184 0.0027
433 HAIR TEXTURE ABNORMAL 36 0.0027
434 PULMONARY HAEMORRHAGE 21 0.0027
435 POLYNEUROPATHY 32 0.0027
436 DYSSTASIA 78 0.0027
437 SUBDURAL HAEMATOMA 38 0.0027
438 ARTHRALGIA 1102 0.0026
439 CHOLECYSTITIS ACUTE 15 0.0026
440 NEUTROPHILIA 15 0.0026
441 PAIN OF SKIN 71 0.0026
442 DISCOMFORT 160 0.0026
443 ABDOMINAL TENDERNESS 13 0.0026
444 MALAISE 1146 0.0026
445 HERPES VIRUS INFECTION 15 0.0026
446 CEREBRAL HAEMORRHAGE 93 0.0026
447 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
448 FACIAL PAIN 23 0.0026
449 CORONAVIRUS INFECTION 17 0.0026
450 HYPOPHOSPHATAEMIA 19 0.0026
451 POLYURIA 21 0.0026
452 CORONARY ARTERIAL STENT INSERTION 13 0.0026
453 INFLAMMATION 132 0.0026
454 GASTROINTESTINAL INFLAMMATION 20 0.0026
455 LIMB DISCOMFORT 79 0.0026
456 OROPHARYNGEAL DISCOMFORT 23 0.0025
457 BLOOD GLUCOSE ABNORMAL 47 0.0025
458 PALPITATIONS 298 0.0025
459 CONSTIPATION 554 0.0025
460 INTERNAL HAEMORRHAGE 29 0.0025
461 NEOPLASM 29 0.0025
462 VISION BLURRED 346 0.0025
463 OBESITY 40 0.0025
464 HEART RATE ABNORMAL 14 0.0025
465 ANXIETY 711 0.0025
466 AORTIC ANEURYSM 19 0.0025
467 ILEUS 31 0.0025
468 INFLUENZA 278 0.0025
469 BLOOD PRESSURE INCREASED 381 0.0025
470 VISUAL FIELD DEFECT 18 0.0025
471 HEPATITIS B 15 0.0025
472 SKIN ULCER 64 0.0025
473 LABORATORY TEST ABNORMAL 73 0.0025
474 DYSPNOEA 1398 0.0025
475 MUSCLE DISORDER 20 0.0025
476 INGUINAL HERNIA 15 0.0025
477 BLOOD POTASSIUM INCREASED 40 0.0025
478 OEDEMA PERIPHERAL 300 0.0025
479 MOTOR DYSFUNCTION 25 0.0025
480 MOUTH SWELLING 14 0.0024
481 SPEECH DISORDER 127 0.0024
482 BLOOD TEST ABNORMAL 34 0.0024
483 HYPERTHYROIDISM 35 0.0024
484 SUPRAVENTRICULAR TACHYCARDIA 23 0.0024
485 URINE OUTPUT DECREASED 21 0.0024
486 HEADACHE 1503 0.0024
487 RETINAL DETACHMENT 22 0.0024
488 CHROMATURIA 54 0.0024
489 DRY SKIN 319 0.0024
490 INCORRECT DRUG ADMINISTRATION DURATION 67 0.0024
491 ABDOMINAL DISTENSION 248 0.0024
492 BLOOD PRESSURE ABNORMAL 47 0.0024
493 NECK PAIN 131 0.0023
494 CHEST DISCOMFORT 240 0.0023
495 HEPATIC CIRRHOSIS 44 0.0023
496 HELICOBACTER INFECTION 24 0.0023
497 SKIN HYPERPIGMENTATION 20 0.0023
498 LUNG DISORDER 114 0.0023
499 ONYCHOCLASIS 16 0.0023
500 ACUTE PULMONARY OEDEMA 13 0.0023
501 CARDIAC ARREST 191 0.0023
502 DEPRESSED MOOD 122 0.0023
503 BODY TEMPERATURE INCREASED 47 0.0023
504 HUNGER 32 0.0023
505 RENAL DISORDER 107 0.0023
506 MENSTRUAL DISORDER 19 0.0023
507 EMBOLISM 19 0.0023
508 WEIGHT DECREASED 638 0.0023
509 GLAUCOMA 44 0.0023
510 HAEMORRHAGE INTRACRANIAL 34 0.0023
511 VOMITING 1067 0.0023
512 PRODUCT DISTRIBUTION ISSUE 21 0.0023
513 ACCIDENT 27 0.0023
514 BREAST PAIN 24 0.0022
515 SKIN MASS 15 0.0022
516 LIMB INJURY 61 0.0022
517 BACK PAIN 521 0.0022
518 EYELID OEDEMA 26 0.0022
519 POLLAKIURIA 93 0.0022
520 ULCER HAEMORRHAGE 15 0.0022
521 GENERAL PHYSICAL CONDITION ABNORMAL 15 0.0022
522 MUSCULOSKELETAL DISCOMFORT 38 0.0022
523 PAIN 1353 0.0022
524 ACNE 167 0.0022
525 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
526 GASTROOESOPHAGEAL REFLUX DISEASE 176 0.0022
527 GAIT INABILITY 73 0.0022
528 HAIR GROWTH ABNORMAL 15 0.0022
529 CARDIAC FLUTTER 14 0.0022
530 VITAMIN D DEFICIENCY 21 0.0022
531 DIABETES MELLITUS INADEQUATE CONTROL 38 0.0021
532 LIVER FUNCTION TEST INCREASED 46 0.0021
533 NEPHROPATHY TOXIC 24 0.0021
534 SQUAMOUS CELL CARCINOMA 20 0.0021
535 HEPATOCELLULAR INJURY 30 0.0021
536 NEPHROLITHIASIS 97 0.0021
537 PERIPHERAL COLDNESS 29 0.0021
538 APPETITE DISORDER 14 0.0021
539 SKIN DISCOLOURATION 97 0.0021
540 PRODUCT PRESCRIBING ERROR 50 0.0021
541 ABDOMINAL DISCOMFORT 352 0.0021
542 PHARYNGITIS 26 0.0021
543 BLOOD POTASSIUM DECREASED 63 0.0021
544 CARDIAC OPERATION 18 0.0021
545 BLOOD GLUCOSE INCREASED 394 0.0021
546 KIDNEY INFECTION 41 0.0021
547 QUALITY OF LIFE DECREASED 28 0.0021
548 PULMONARY FIBROSIS 40 0.0021
549 FEAR 56 0.0021
550 EMPHYSEMA 21 0.0021
551 DENTAL CARIES 23 0.0021
552 APHONIA 29 0.0021
553 ABNORMAL FAECES 17 0.0021
554 VENTRICULAR FIBRILLATION 23 0.0021
555 DRUG INTERACTION 327 0.0021
556 GAIT DISTURBANCE 394 0.0021
557 GROIN PAIN 18 0.0020
558 BLOOD CALCIUM DECREASED 23 0.0020
559 SARS-COV-2 TEST POSITIVE 27 0.0020
560 SWELLING 191 0.0020
561 AFFECTIVE DISORDER 16 0.0020
562 PSYCHIATRIC SYMPTOM 15 0.0020
563 ENCEPHALITIS 14 0.0020
564 ATAXIA 24 0.0020
565 OVARIAN CYST 20 0.0020
566 HEAVY MENSTRUAL BLEEDING 18 0.0020
567 VENTRICULAR TACHYCARDIA 33 0.0020
568 RIGHT VENTRICULAR FAILURE 14 0.0020
569 INCREASED APPETITE 38 0.0020
570 PAROSMIA 15 0.0020
571 IMMUNE SYSTEM DISORDER 26 0.0020
572 VERTIGO 120 0.0020
573 NAUSEA 1557 0.0020
574 RHINORRHOEA 127 0.0020
575 NEUTROPHIL COUNT DECREASED 80 0.0020
576 ILLNESS 201 0.0019
577 NEUTROPENIA 265 0.0019
578 DIFFUSE LARGE B-CELL LYMPHOMA 15 0.0019
579 COLON CANCER 29 0.0019
580 IMMUNODEFICIENCY 29 0.0019
581 NAIL DISORDER 17 0.0019
582 HYPOAESTHESIA 290 0.0019
583 SPINAL OSTEOARTHRITIS 17 0.0019
584 METASTASES TO LIVER 34 0.0019
585 HAEMATOMA 50 0.0019
586 PRODUCTIVE COUGH 92 0.0019
587 C-REACTIVE PROTEIN INCREASED 70 0.0019
588 BASAL CELL CARCINOMA 30 0.0019
589 DYSARTHRIA 72 0.0019
590 ORAL DISORDER 14 0.0019
591 DIARRHOEA 1228 0.0019
592 SPINAL DISORDER 18 0.0019
593 BRAIN INJURY 19 0.0019
594 LYMPHOMA 29 0.0019
595 INCORRECT DOSE ADMINISTERED 428 0.0019
596 INSOMNIA 498 0.0019
597 FEELING COLD 52 0.0019
598 LYMPHOCYTE COUNT DECREASED 33 0.0019
599 GLYCOSYLATED HAEMOGLOBIN INCREASED 47 0.0019
600 MASS 26 0.0019
601 HEART RATE IRREGULAR 42 0.0019
602 PNEUMONIA 601 0.0019
603 CARDIAC FAILURE CONGESTIVE 149 0.0019
604 DIZZINESS 925 0.0019
605 DECREASED ACTIVITY 20 0.0019
606 MATERNAL EXPOSURE DURING PREGNANCY 165 0.0018
607 MEMORY IMPAIRMENT 254 0.0018
608 PERIPHERAL SWELLING 284 0.0018
609 RENAL FAILURE 244 0.0018
610 LYMPHADENOPATHY 65 0.0018
611 CONJUNCTIVITIS 34 0.0018
612 SOMNOLENCE 369 0.0018
613 FEEDING DISORDER 37 0.0018
614 LIGAMENT SPRAIN 18 0.0018
615 LOCALISED INFECTION 44 0.0018
616 ABSCESS 29 0.0018
617 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0018
618 HYPERTENSIVE CRISIS 20 0.0018
619 GASTROINTESTINAL DISORDER 161 0.0018
620 VISUAL IMPAIRMENT 222 0.0018
621 WOUND 50 0.0018
622 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 93 0.0018
623 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 126 0.0018
624 ACUTE RESPIRATORY FAILURE 34 0.0018
625 FLATULENCE 100 0.0018
626 NASOPHARYNGITIS 324 0.0018
627 CEREBRAL DISORDER 13 0.0018
628 SECRETION DISCHARGE 22 0.0018
629 ARTHROPOD BITE 13 0.0018
630 BURNING SENSATION 123 0.0018
631 ERECTILE DYSFUNCTION 45 0.0018
632 SEPTIC SHOCK 76 0.0017
633 BRAIN NEOPLASM 16 0.0017
634 INFECTION 252 0.0017
635 OESOPHAGITIS 19 0.0017
636 CONTUSION 167 0.0017
637 CATARACT 103 0.0017
638 LOCAL SWELLING 30 0.0017
639 THERAPY CESSATION 88 0.0017
640 DYSPHONIA 100 0.0017
641 RASH MACULO-PAPULAR 38 0.0017
642 CYST 21 0.0017
643 RENAL IMPAIRMENT 142 0.0017
644 NEURALGIA 41 0.0017
645 SLEEP APNOEA SYNDROME 32 0.0017
646 DYSPHAGIA 159 0.0017
647 HAEMOLYTIC ANAEMIA 15 0.0017
648 CHOLESTASIS 32 0.0017
649 BLISTER 93 0.0017
650 RASH PAPULAR 37 0.0016
651 FALL 546 0.0016
652 DYSURIA 60 0.0016
653 SWELLING FACE 106 0.0016
654 MULTIPLE ORGAN DYSFUNCTION SYNDROME 46 0.0016
655 DRY EYE 81 0.0016
656 MYOPATHY 14 0.0016
657 OROPHARYNGEAL PAIN 150 0.0016
658 MULTI-ORGAN FAILURE 28 0.0016
659 NEUROPATHY PERIPHERAL 154 0.0016
660 MUSCLE STRAIN 14 0.0016
661 MOOD ALTERED 44 0.0016
662 RESPIRATORY DISORDER 48 0.0016
663 AMNESIA 104 0.0016
664 THROMBOSIS 127 0.0016
665 PRODUCT PACKAGING ISSUE 15 0.0016
666 HAEMORRHAGE 165 0.0016
667 EYE INFLAMMATION 15 0.0016
668 VISUAL ACUITY REDUCED 52 0.0016
669 NOCTURIA 19 0.0016
670 RESPIRATORY FAILURE 114 0.0016
671 GASTROINTESTINAL INFECTION 14 0.0016
672 FEELING ABNORMAL 374 0.0016
673 TEMPERATURE INTOLERANCE 16 0.0015
674 CELLULITIS 78 0.0015
675 SLEEP DISORDER 109 0.0015
676 OSTEOARTHRITIS 65 0.0015
677 VIRAL INFECTION 51 0.0015
678 OVARIAN CANCER 14 0.0015
679 POST PROCEDURAL COMPLICATION 29 0.0015
680 GASTROENTERITIS 22 0.0015
681 BLOOD MAGNESIUM DECREASED 13 0.0015
682 APPENDICITIS 14 0.0015
683 HYPERHIDROSIS 193 0.0015
684 SKIN REACTION 21 0.0015
685 POOR QUALITY SLEEP 32 0.0015
686 BLOOD SODIUM DECREASED 28 0.0015
687 NEUROTOXICITY 26 0.0015
688 SUBARACHNOID HAEMORRHAGE 15 0.0015
689 BRONCHITIS 109 0.0015
690 METASTASES TO LUNG 17 0.0015
691 WEIGHT INCREASED 329 0.0015
692 PNEUMONITIS 40 0.0015
693 DRUG ADMINISTRATION ERROR 45 0.0015
694 EAR DISCOMFORT 15 0.0015
695 EYE DISORDER 48 0.0015
696 VASCULITIS 17 0.0015
697 RESPIRATORY TRACT INFECTION 38 0.0015
698 DISEASE PROGRESSION 172 0.0015
699 SINUS BRADYCARDIA 14 0.0014
700 ERUCTATION 28 0.0014
701 RED BLOOD CELL SEDIMENTATION RATE INCREASED 16 0.0014
702 TENDERNESS 15 0.0014
703 ARTHRITIS 113 0.0014
704 OSTEOMYELITIS 26 0.0014
705 BLOOD PRESSURE SYSTOLIC INCREASED 28 0.0014
706 CHOKING 28 0.0014
707 WEIGHT FLUCTUATION 15 0.0014
708 HYPOKALAEMIA 66 0.0014
709 EOSINOPHILIA 25 0.0014
710 RASH ERYTHEMATOUS 68 0.0014
711 MUSCULAR WEAKNESS 161 0.0014
712 FUNGAL INFECTION 47 0.0014
713 PULMONARY MASS 21 0.0014
714 SINUS TACHYCARDIA 20 0.0014
715 RETCHING 30 0.0014
716 HAEMOPTYSIS 39 0.0014
717 HERNIA 27 0.0014
718 HYPERSENSITIVITY 259 0.0014
719 HYPOXIA 49 0.0014
720 HIATUS HERNIA 18 0.0014
721 PRODUCT PHYSICAL ISSUE 28 0.0014
722 GASTROENTERITIS VIRAL 25 0.0014
723 HYPOMAGNESAEMIA 19 0.0014
724 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 14 0.0014
725 ROAD TRAFFIC ACCIDENT 57 0.0014
726 COLD SWEAT 24 0.0014
727 ADVERSE REACTION 18 0.0014
728 CARPAL TUNNEL SYNDROME 19 0.0014
729 POISONING 17 0.0014
730 THIRST 24 0.0013
731 LOSS OF CONSCIOUSNESS 172 0.0013
732 MUSCLE ATROPHY 17 0.0013
733 FAECES DISCOLOURED 29 0.0013
734 MUCOSAL INFLAMMATION 35 0.0013
735 EYE INFECTION 15 0.0013
736 SCRATCH 14 0.0013
737 MENORRHAGIA 26 0.0013
738 EPISTAXIS 99 0.0013
739 HAEMATOCHEZIA 73 0.0013
740 RESTLESS LEGS SYNDROME 24 0.0013
741 NERVOUS SYSTEM DISORDER 41 0.0013
742 FEBRILE NEUTROPENIA 87 0.0013
743 DRUG DISPENSING ERROR 20 0.0013
744 FLUID OVERLOAD 19 0.0013
745 COVID-19 229 0.0013
746 NODULE 17 0.0013
747 APATHY 19 0.0013
748 THERAPY INTERRUPTED 93 0.0013
749 ANGER 44 0.0013
750 INTERSTITIAL LUNG DISEASE 63 0.0013
751 DEPRESSION 296 0.0013
752 DIVERTICULITIS 36 0.0013
753 UPPER RESPIRATORY TRACT INFECTION 60 0.0013
754 HEPATIC FAILURE 39 0.0013
755 SNEEZING 29 0.0013
756 LACRIMATION INCREASED 39 0.0013
757 GALLBLADDER DISORDER 23 0.0013
758 MOUTH ULCERATION 27 0.0013
759 HIP FRACTURE 41 0.0013
760 GASTROINTESTINAL PAIN 14 0.0013
761 HEART RATE INCREASED 126 0.0013
762 COLITIS 48 0.0013
763 NERVOUSNESS 66 0.0013
764 FOOT DEFORMITY 14 0.0013
765 LIVER INJURY 31 0.0013
766 TOOTH DISORDER 28 0.0013
767 MACULAR DEGENERATION 15 0.0013
768 HEPATIC CYTOLYSIS 16 0.0013
769 AGEUSIA 31 0.0012
770 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
771 RECTAL HAEMORRHAGE 53 0.0012
772 BACTERIAL INFECTION 23 0.0012
773 SCAB 14 0.0012
774 TENDONITIS 19 0.0012
775 GASTRIC DISORDER 42 0.0012
776 ORAL DISCOMFORT 17 0.0012
777 OCULAR HYPERAEMIA 58 0.0012
778 SMALL INTESTINAL OBSTRUCTION 15 0.0012
779 HERPES ZOSTER 70 0.0012
780 SKIN HAEMORRHAGE 18 0.0012
781 PAIN IN JAW 34 0.0012
782 MENTAL DISORDER 52 0.0012
783 MALIGNANT MELANOMA 16 0.0012
784 INTESTINAL OBSTRUCTION 45 0.0012
785 PRODUCT DISPENSING ERROR 26 0.0012
786 DERMATITIS 25 0.0012
787 EYE PRURITUS 40 0.0012
788 IMPAIRED HEALING 39 0.0012
789 BLOOD GLUCOSE FLUCTUATION 13 0.0012
790 DISORIENTATION 47 0.0012
791 HYPERSOMNIA 34 0.0012
792 CARDIOGENIC SHOCK 17 0.0012
793 ERYTHEMA 243 0.0012
794 BACTERAEMIA 14 0.0012
795 DRUG-INDUCED LIVER INJURY 37 0.0012
796 MUSCLE TIGHTNESS 19 0.0012
797 ECZEMA 61 0.0012
798 HEPATITIS C 14 0.0012
799 CRYING 42 0.0012
800 PARAESTHESIA 181 0.0011
801 HEART RATE DECREASED 40 0.0011
802 EMOTIONAL DISORDER 35 0.0011
803 COGNITIVE DISORDER 53 0.0011
804 TASTE DISORDER 23 0.0011
805 BRADYCARDIA 60 0.0011
806 EYE SWELLING 42 0.0011
807 DRUG ERUPTION 20 0.0011
808 HYPOAESTHESIA ORAL 17 0.0011
809 SENSORY DISTURBANCE 18 0.0011
810 ILL-DEFINED DISORDER 68 0.0011
811 IRRITABLE BOWEL SYNDROME 24 0.0011
812 DISEASE RECURRENCE 53 0.0011
813 HYPERKALAEMIA 39 0.0011
814 FRACTURE 21 0.0011
815 BLOOD URINE PRESENT 21 0.0011
816 ANOSMIA 16 0.0011
817 TACHYPNOEA 15 0.0011
818 PRESCRIBED UNDERDOSE 22 0.0011
819 PELVIC PAIN 20 0.0011
820 CYSTITIS 35 0.0011
821 BLOOD PRESSURE DECREASED 73 0.0011
822 MEDICATION ERROR 61 0.0011
823 HYPOPHAGIA 28 0.0011
824 ADVERSE DRUG REACTION 98 0.0011
825 NASAL CONGESTION 64 0.0011
826 DRUG LEVEL INCREASED 18 0.0011
827 BLOOD PRESSURE FLUCTUATION 26 0.0011
828 GASTROINTESTINAL HAEMORRHAGE 90 0.0011
829 JOINT INJURY 23 0.0011
830 HEAD INJURY 34 0.0011
831 ORAL PAIN 24 0.0011
832 DRY MOUTH 86 0.0011
833 PROTEINURIA 20 0.0011
834 RESPIRATORY DISTRESS 29 0.0010
835 DEHYDRATION 139 0.0010
836 END STAGE RENAL DISEASE 19 0.0010
837 LOWER LIMB FRACTURE 20 0.0010
838 PRODUCT USE ISSUE 195 0.0010
839 URINARY TRACT INFECTION 176 0.0010
840 SKIN EXFOLIATION 87 0.0010
841 BRAIN OEDEMA 13 0.0010
842 LUNG NEOPLASM MALIGNANT 42 0.0010
843 RESPIRATORY ARREST 28 0.0010
844 URINARY INCONTINENCE 30 0.0010
845 ABASIA 25 0.0010
846 COORDINATION ABNORMAL 14 0.0010
847 PNEUMONIA ASPIRATION 25 0.0010
848 HOT FLUSH 75 0.0010
849 FEELING HOT 61 0.0010
850 LETHARGY 57 0.0010
851 VAGINAL HAEMORRHAGE 43 0.0010
852 DRUG PRESCRIBING ERROR 19 0.0010
853 BONE DISORDER 18 0.0010
854 FIBROMYALGIA 24 0.0010
855 BACK DISORDER 16 0.0010
856 BALANCE DISORDER 85 0.0010
857 PHARYNGEAL OEDEMA 15 0.0010
858 METASTASES TO BONE 16 0.0010
859 RIB FRACTURE 20 0.0010
860 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
861 DEPRESSED LEVEL OF CONSCIOUSNESS 38 0.0010
862 RHABDOMYOLYSIS 40 0.0010
863 SHOCK 22 0.0010
864 MELAENA 21 0.0010
865 ABDOMINAL PAIN LOWER 24 0.0009
866 EPILEPSY 29 0.0009
867 ABORTION SPONTANEOUS 38 0.0009
868 URTICARIA 158 0.0009
869 OSTEOPOROSIS 38 0.0009
870 DRUG INEFFECTIVE 1215 0.0009
871 PRODUCT DOSE OMISSION ISSUE 270 0.0009
872 BLOOD GLUCOSE DECREASED 44 0.0009
873 DEVICE RELATED INFECTION 14 0.0009
874 MENTAL STATUS CHANGES 25 0.0009
875 SINUSITIS 92 0.0009
876 GLOSSODYNIA 20 0.0009
877 BRAIN FOG 14 0.0009
878 DISTURBANCE IN ATTENTION 48 0.0009
879 PREMATURE DELIVERY 14 0.0009
880 SCAR 15 0.0009
881 SKIN IRRITATION 40 0.0009
882 TOXICITY TO VARIOUS AGENTS 147 0.0009
883 LOWER RESPIRATORY TRACT INFECTION 39 0.0009
884 UPPER LIMB FRACTURE 17 0.0009
885 ARTHROPATHY 47 0.0008
886 CHRONIC KIDNEY DISEASE 64 0.0008
887 CONFUSIONAL STATE 136 0.0008
888 MIGRAINE 80 0.0008
889 MUSCULOSKELETAL STIFFNESS 73 0.0008
890 PREMATURE BABY 25 0.0008
891 RASH MACULAR 29 0.0008
892 CANDIDA INFECTION 14 0.0008
893 PRODUCT DOSE OMISSION 54 0.0008
894 EAR INFECTION 22 0.0008
895 CYANOSIS 13 0.0008
896 RENAL FAILURE ACUTE 35 0.0008
897 STOMATITIS 50 0.0008
898 OSTEONECROSIS 27 0.0008
899 MOBILITY DECREASED 59 0.0008
900 TOOTH LOSS 17 0.0008
901 AGRANULOCYTOSIS 15 0.0008
902 THERAPEUTIC RESPONSE UNEXPECTED 36 0.0008
903 SKIN CANCER 17 0.0008
904 HOSPITALISATION 121 0.0008
905 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18 0.0008
906 DEEP VEIN THROMBOSIS 50 0.0008
907 DYSGEUSIA 57 0.0008
908 JOINT STIFFNESS 20 0.0008
909 SINUS DISORDER 15 0.0008
910 JOINT SWELLING 91 0.0008
911 PRODUCT USE IN UNAPPROVED INDICATION 186 0.0007
912 CYTOKINE RELEASE SYNDROME 15 0.0007
913 EYE IRRITATION 43 0.0007
914 SEIZURE 86 0.0007
915 AMENORRHOEA 13 0.0007
916 FOOT FRACTURE 14 0.0007
917 PERITONITIS 15 0.0007
918 LIP SWELLING 24 0.0007
919 ORAL HERPES 14 0.0007
920 ASTHMA 79 0.0007
921 ENCEPHALOPATHY 17 0.0007
922 URINARY RETENTION 23 0.0007
923 PROCEDURAL PAIN 19 0.0007
924 RESTLESSNESS 25 0.0007
925 SWOLLEN TONGUE 21 0.0007
926 HYPOTENSION 133 0.0007
927 HYPOGLYCAEMIA 32 0.0007
928 OXYGEN SATURATION DECREASED 37 0.0007
929 HYPONATRAEMIA 37 0.0007
930 TREMOR 109 0.0007
931 MULTIPLE SCLEROSIS 31 0.0006
932 ACUTE KIDNEY INJURY 99 0.0006
933 RENAL INJURY 19 0.0006
934 ANGIOEDEMA 28 0.0006
935 GASTRIC CANCER 16 0.0006
936 THROAT IRRITATION 28 0.0006
937 PULMONARY EMBOLISM 59 0.0006
938 GYNAECOMASTIA 19 0.0006
939 STAPHYLOCOCCAL INFECTION 20 0.0006
940 EXPIRED PRODUCT ADMINISTERED 20 0.0006
941 SKIN BURNING SENSATION 43 0.0006
942 MENSTRUATION IRREGULAR 16 0.0006
943 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
944 WHEEZING 35 0.0006
945 AGITATION 43 0.0006
946 MENTAL IMPAIRMENT 14 0.0006
947 ACCIDENTAL OVERDOSE 21 0.0006
948 TREATMENT NONCOMPLIANCE 31 0.0006
949 WRONG TECHNIQUE IN DRUG USAGE PROCESS 20 0.0005
950 IRRITABILITY 33 0.0005
951 WITHDRAWAL SYNDROME 23 0.0005
952 INFLUENZA LIKE ILLNESS 45 0.0005
953 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0005
954 PROSTATE CANCER 43 0.0005
955 MOOD SWINGS 17 0.0005
956 BREAST CANCER 49 0.0005
957 UNDERDOSE 38 0.0005
958 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 37 0.0005
959 FOETAL EXPOSURE DURING PREGNANCY 40 0.0005
960 CONVULSION 28 0.0005
961 PANCREATIC CARCINOMA 14 0.0005
962 MYELOSUPPRESSION 17 0.0005
963 OFF LABEL USE 409 0.0005
964 PANIC ATTACK 17 0.0005
965 PLASMA CELL MYELOMA 18 0.0005
966 DELIRIUM 16 0.0005
967 CONDITION AGGRAVATED 136 0.0004
968 FLUSHING 45 0.0004
969 LACTIC ACIDOSIS 14 0.0004
970 UNEVALUABLE EVENT 32 0.0004
971 RENAL CANCER 20 0.0004
972 PRODUCT STORAGE ERROR 36 0.0004
973 ADVERSE EVENT 37 0.0004
974 NO ADVERSE EVENT 70 0.0004
975 SURGERY 22 0.0004
976 EXPOSURE DURING PREGNANCY 23 0.0004
977 DRUG DOSE OMISSION 60 0.0004
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 73 0.0004
979 ABNORMAL BEHAVIOUR 14 0.0004
980 ANAPHYLACTIC REACTION 19 0.0003
981 RHEUMATOID ARTHRITIS 38 0.0003
982 HALLUCINATION 25 0.0003
983 SUICIDAL IDEATION 27 0.0003
984 PSORIASIS 36 0.0003
985 AGGRESSION 13 0.0003
986 SUICIDE ATTEMPT 15 0.0002
987 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
988 PRODUCT QUALITY ISSUE 31 0.0002
989 OVERDOSE 49 0.0002
990 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0001